U.S., June 3 -- ClinicalTrials.gov registry received information related to the study (NCT07621601) titled 'A Study of HS-20093 in Patients With Pretreated Advanced or Metastatic Esophageal Squamous Cell Carcinoma (ESCC)' on May 26.
Brief Summary: This is a multicenter, randomized, open-label, controlled phase III clinical study to evaluate the efficacy and safety of HS-20093- injection versus investigator's choice of chemotherapy in patients with locally advanced or metastatic esophageal squamous cell carcinoma after progress of first-line standard therapy.
Study Start Date: July 31
Study Type: INTERVENTIONAL
Condition:
Esophageal Squamous Cell Carcinoma (ESCC)
Intervention:
DRUG: HS-20093 for Injection
The patient will receive tre...